{
  "uuid" : "",
  "id" : "Lille_Model_for_Alcoholic_Hepatitis.v0.0.1",
  "gdl_version" : "2.1",
  "concept" : "gt0001",
  "language" : {
    "original_language" : "ISO_639-1::en"
  },
  "description" : {
    "original_author" : {
      "name" : "Katja Mariko Wilde",
      "email" : "katja-wilde@t-online.de",
      "organisation" : "Cambio CDS",
      "date" : "2025-10-28"
    },
    "lifecycle_state" : "DRAFTED",
    "details" : {
      "en" : {
        "id" : "en",
        "purpose" : "To calculate the Lille Model score for patients with alcoholic hepatitis treated with steroids, in order to identify non-responders and support decisions for alternative management or early referral for liver transplantation.",
        "keywords" : [
          "lille",
          "model",
          "alcoholic",
          "hepatitis",
          "albumin",
          "bilirubin",
          "creatinine",
          "pt",
          "mortality"
        ],
        "use" : "Use to predict the 6-month survival of patients with alcoholic hepatitis after 7 days of steroid therapy.\n\nThe Lille Model score is calculated using the following variables:\n\nAge (years)\nAlbumin (g/L) at day 0\nBilirubin (µmol/L) at day 0 and day 7 (to calculate bilirubin evolution)\nCreatinine (µmol/L) to determine renal insufficiency\nProthrombin time (sec)\n\nDerived binary variable “renal insufficiency” (1 if Cr > 115 µmol/L or >1.3 mg/dL; otherwise 0)\n\nThe final Lille score is computed using the published formula and can support clinical decision-making regarding ongoing therapy or referral for transplantation.\n\nR = 3.19 – 0.101*(age, years) + 0.147*(albumin day 0, g/L) + 0.0165* (evolution in bilirubin level, µmol/L) - 0.206*(renal insufficiency) - 0.0065*(bilirubin day 0, µmol/L) - 0.0096*(PT, sec)",
        "misuse" : "Not to be used for recording information related to other prognostic models in alcoholic hepatitis.",
        "copyright" : "© Cambio CDS"
      }
    },
    "other_details" : {
      "references" : "Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007 Jun;45(6):1348-54. doi: 10.1002/hep.21607. PMID: 17518367.",
      "en" : "An assessment score used to predict 6-month mortality in patients with alcoholic hepatitis who have not responded to steroid therapy after 7 days."
    }
  },
  "definition" : { },
  "ontology" : {
    "term_definitions" : {
      "en" : {
        "id" : "en",
        "terms" : {
          "gt0001" : {
            "id" : "gt0001",
            "text" : "Lille Model for Alcoholic Hepatitis",
            "description" : "An assessment score used to predict 6-month mortality in patients with alcoholic hepatitis who have not responded to steroid therapy after 7 days."
          }
        }
      }
    }
  }
}